Angany immunotherapy platform attracting attention from major players
Franco-Canadian start-up Angany claims to be “gaining momentum” for its plant-based immunotherapy platform. The firm aims to leverage the immunogenicity and safety profile of its plant-based eBioparticle technology for the development of therapeutic vaccines. Angany is working in both the human pharma and animal health sectors. It is targeting applications in allergy, autoimmune diseases, chronic […]
LEVOYA partners with Avianax
Avianax and LEVOYA entered an agreement to develop business opportunities in the veterinary industry, with an initial focus in concluding a licensing agreement with an Animal Health company for ParvoONE, Avianax therapeutic antibodies for Canine Parvovirus. Canine Parvovirus is a highly contagious and relatively common cause of acute, infectious GI illness in young and/or unvaccinated dogs. Despite almost […]
It’s time to give back!
LOOKING AHEAD… Most of the year we dedicate our efforts to helping our clients build their future business. But as we get ready to celebrate this Holiday Season it just feels right to pause and help those who make an effort to protect Nature and leave a healthier, cleaner Planet for all our children. …STARTING […]
